ABIOMED Stock News

State of Alaska Department of Revenue boosted its stake in ABIOMED, Inc. (NASDAQ:ABMD) by 2.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owne

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F

ABIOMED, Inc. (NASDAQ:ABMD) saw a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 2,360,000 shares, a drop of 13.6% from the June 15th total of 2

The

The expanding market opportunity and superior financial metrics has me bullish on Abiomed. Even with an economic slowdown, I expect Abiomed to grow net profits by 15% annually due to the continued ado

ABIOMED, Inc. (NASDAQ:ABMD) has been assigned a consensus recommendation of “Hold” from the twelve brokerages that are presently covering the firm, Marketbeat reports. Two equities research analys

Titan Medical (NASDAQ:TMDI) and ABIOMED (NASDAQ:ABMD) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability,

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the closing of concurr

We are in a Work From Home World, and Wall Street knows it.

Axa increased its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 16.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. Th

Laut der ersten in den USA veröffentlichten Studie von Patienten, die die neueste Herzpumpe von Abiomed, die Impella 5.5 mit SmartAssist, erhalten hab

The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to explant with 76% native heart r

A select group of stocks rose in the second quarter and for all of 2020.